Bristol-Myers, States Settle Plavix Case For $1.1M

Law360, New York (December 29, 2008, 12:00 AM EST) -- Bristol-Myers Squibb Co. has agreed to pay $1.1 million to settle allegations by attorneys general nationwide that the drugmaker misled the states about a proposed Plavix patent deal with Apotex Corp. in 2006, a violation of court orders stemming from two earlier antitrust cases.

Under the settlement — inked between Bristol-Myers and all 50 states, the District of Columbia and four U.S. territories — the drugmaker accepted responsibility for subverting the reporting requirements established by earlier settlements with the attorneys general over its Buspar and Taxol...
To view the full article, register now.